Paula L. Hyland

United States Food and Drug Administration

Also affiliated with Center for Drug Evaluation and Research

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Leveraging in Vitro Models for Clinically Relevant Rare CYP2D6 Variants in Pharmacogenomics”.

Leveraging in Vitro Models for Clinically Relevant Rare CYP2D6 Variants in Pharmacogenomics

Drug Metabolism and Disposition(2024)10.1124/dmd.123.001512

N/A

0.126DataRank · unranked

1 citations

Paula L. Hyland, Michael Pacanowski, Robert N. Schuck, Sydney Stern

Genome‐wide association study of café‐au‐lait macule number in neurofibromatosis type 1

Molecular Genetics & Genomic Medicine(2020)10.1002/mgg3.1400

N/A

0DataRank · unranked

5 citations

Paula L. Hyland, Alexander Pemov, Jeremy Sabourin, Andrea Baldwin, Sara Bass +6 more

Proteomic Identification of Plasma Biomarkers of Response to IL‐5 Inhibitor Biologics in Healthy Subjects

Clinical and Translational Science(2025)10.1111/cts.70412

N/A

0DataRank · unranked

0 citations

Deepti Pranay Samarth, Kristina E. Howard, Yan Guo, Esraa G. Mohamed, Erica Decker +10 more